{"id":"https://openalex.org/W4361246722","doi":"https://doi.org/10.1158/0008-5472.c.6496566.v1","title":"Data from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma","display_name":"Data from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361246722","doi":"https://doi.org/10.1158/0008-5472.c.6496566.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6496566.v1","doi":"https://doi.org/10.1158/0008-5472.c.6496566.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6496566.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6496566.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108410851","display_name":"David V. Gold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David V. Gold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Goldenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045775470","display_name":"Habibe Karacay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Habibe Karacay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966471","display_name":"Edmund A. Rossi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edmund A. Rossi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109346302","display_name":"Chien\u2010Hsing Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chien-Hsing Chang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018738015","display_name":"Thomas M. Cardillo","orcid":"https://orcid.org/0000-0002-9427-8358","observed_orcids":["https://orcid.org/0000-0002-9427-8358"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas M. Cardillo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"William J. McBride","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William J. McBride","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5043569662","display_name":"Robert M. Sharkey","orcid":"https://orcid.org/0000-0003-1408-0905","observed_orcids":["https://orcid.org/0000-0003-1408-0905"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. Sharkey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pam-4","display_name":"PAM-4","score":0.8209999799728394},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/pretargeting","display_name":"pretargeting","score":0.9039999842643738},{"id":"https://openalex.org/keywords/radiolabeled-peptides","display_name":"radiolabeled peptides","score":0.5889999866485596},{"id":"https://openalex.org/keywords/radionuclide-imaging","display_name":"scintigraphy","score":0.5590000152587891},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-uptake","display_name":"tumor uptake","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2777836882","wikidata":"https://www.wikidata.org/wiki/Q22907915","display_name":"Pretargeting","level":5,"score":0.8075525760650635},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.7464444637298584},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7159964442253113},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.5866373181343079},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5834789276123047},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5218787789344788},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.47179025411605835},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.4438932538032532},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4414258599281311},{"id":"https://openalex.org/C29144244","wikidata":"https://www.wikidata.org/wiki/Q506441","display_name":"Hapten","level":3,"score":0.43918704986572266},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41721975803375244},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39420029520988464},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36893242597579956},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2523239552974701},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2113335132598877},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1810348629951477},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17450380325317383},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15068233013153076},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11447775363922119},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1097034215927124},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.09967070817947388},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6496566.v1","doi":"https://doi.org/10.1158/0008-5472.c.6496566.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6496566.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6496566.v1","doi":"https://doi.org/10.1158/0008-5472.c.6496566.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6496566.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7799999713897705,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1991908200","https://openalex.org/W2241006746","https://openalex.org/W2133255804","https://openalex.org/W2134736445","https://openalex.org/W2268900098","https://openalex.org/W1543566929","https://openalex.org/W2401018260","https://openalex.org/W50488002","https://openalex.org/W2128110805","https://openalex.org/W2165418706"],"abstract_inverted_index":{"Abstract":[0],"Preclinical":[1],"and":[2,15,44,55,66,154,251],"clinical":[3],"studies":[4,65],"have":[5,21],"demonstrated":[6],"the":[7,24,61,70,92,127,130,152,171,176,204,237],"application":[8],"of":[9,17,26,69,129,144,157,175,253],"radiolabeled":[10,39,71,145,260],"mAb-PAM4":[11,54],"for":[12,41,53,57,185,203,247],"nuclear":[13,67],"imaging":[14,43,68,147,246],"radioimmunotherapy":[16],"pancreatic":[18,85,254],"carcinoma.":[19],"We":[20],"now":[22],"examined":[23],"ability":[25],"a":[27,38,48,230],"novel":[28],"PAM4-based,":[29],"bispecific":[30,50],"monoclonal":[31],"antibody":[32],"(mAb)":[33],"construct,":[34],"TF10,":[35],"to":[36,97],"pretarget":[37],"peptide":[40],"improved":[42,245],"therapy.":[45],"TF10":[46,72,241],"is":[47],"humanized,":[49],"mAb,":[51],"divalent":[52],"monovalent":[56],"mAb-679,":[58],"reactive":[59],"against":[60],"histamine-succinyl-glycine":[62],"hapten.":[63],"Biodistribution":[64],"and/or":[73],"TF10-pretargeted":[74,177],"hapten-peptide":[75],"(IMP-288)":[76],"were":[77,200],"conducted":[78],"in":[79,121,159,167],"nude":[80],"mice":[81],"bearing":[82],"CaPan1":[83],"human":[84],"cancer":[86,255],"xenografts.":[87],"125I-TF10":[88],"cleared":[89],"rapidly":[90],"from":[91],"blood,":[93],"with":[94,118,212,258],"levels":[95],"decreasing":[96],"<1%":[98],"injected":[99],"dose":[100,222],"per":[101],"gram":[102],"(ID/g)":[103],"by":[104],"16":[105,136,196],"hours.":[106,197],"Tumor":[107,173],"uptake":[108,150,174],"was":[109,134,165,179,189],"3.47":[110],"\u00b1":[111,181,192],"0.66%":[112],"ID/g":[113,194],"at":[114,195,208,215],"this":[115],"time":[116],"point":[117],"no":[119,155],"accumulation":[120],"any":[122,160],"normal":[123,161],"tissue.":[124,162],"To":[125],"show":[126],"utility":[128],"pretargeting":[131,205,227,242],"approach,":[132],"111In-IMP-288":[133,178,186],"administered":[135],"hours":[137,142],"after":[138],"TF10.":[139],"At":[140],"3":[141,209],"postadministration":[143],"peptide,":[146],"showed":[148],"intense":[149],"within":[151],"tumors":[153],"evidence":[156],"accretion":[158],"No":[163],"targeting":[164],"observed":[166],"animals":[168],"given":[169],"only":[170,190],"111In-peptide.":[172],"24.3":[180],"1.7%":[182],"ID/g,":[183],"whereas":[184],"alone":[187],"it":[188],"0.12":[191],"0.002%":[193],"Tumor/blood":[198],"ratios":[199],"significantly":[201],"greater":[202,231],"group":[206],"(\u223c1,000:1":[207],"hours)":[210],"compared":[211,257],"111In-PAM4-IgG":[213],"(\u223c5:1":[214],"24":[216],"hours;":[217],"P":[218],"<":[219],"0.0003).":[220],"Radiation":[221],"estimates":[223],"suggested":[224],"that":[225,240],"TF10/90Y-peptide":[226],"would":[228],"provide":[229,244],"antitumor":[232],"effect":[233],"than":[234],"90Y-PAM4-IgG.":[235],"Thus,":[236],"results":[238],"suggest":[239],"may":[243],"early":[248],"detection,":[249],"diagnosis,":[250],"treatment":[252],"as":[256],"directly":[259],"PAM4-IgG.":[261],"[Cancer":[262],"Res":[263],"2008;68(12):4819\u201326]":[264]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-03-31T00:00:00"}